Switzerland-based Roche Holdings AG has begun the reshuffling process of several of its executives following its $46.8 billion takeover of biotechnology company Genentech in March.

Jaclyn Jaeger is a freelance contributor to Compliance Week after working for the company for 15 years. She writes on a wide variety of topics, including ethics and compliance, risk management, legal,...